Status:
NOT_YET_RECRUITING
Role of Frailty in Bleeding Risk Prediction in Acute Coronary Syndrome
Lead Sponsor:
Assiut University
Conditions:
Frailty
Acute Coronary Syndrome
Eligibility:
All Genders
65+ years
Brief Summary
Studying the incremental role of frailty in predicting in-hospital, short-term (30 days), and mid-term (6 months) bleeding in ACS patients.
Detailed Description
Potent platelet inhibition reduces the risk of thrombotic complications in patients with acute coronary syndromes. Unavoidably, the more potent platelet inhibition increases the risk of bleeding. Blee...
Eligibility Criteria
Inclusion
- \- Patients must be suffering from acute coronary syndrome ( STEMI - NSTEMI ) at the time of recruitment
- \- Patients must be older than 65 years
Exclusion
- \- Patients younger than 65 years
- \- Refusal of participation
- \- In - hospital death unrelated to bleeding
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2027
Estimated Enrollment :
850 Patients enrolled
Trial Details
Trial ID
NCT07158788
Start Date
October 1 2025
End Date
September 1 2027
Last Update
September 8 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.